tiprankstipranks
Vectus Biosystems Limited (AU:VBS)
ASX:VBS
Australian Market

Vectus Biosystems Limited (VBS) Share Price & Analysis

1 Followers

VBS Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.10 - AU$0.65
Previous CloseAU$0.29
VolumeN/A
Average Volume (3M)15.71K
Market Cap
N/A
Enterprise ValueAU$19.90M
Total Cash (Recent Filing)AU$1.28M
Total Debt (Recent Filing)AU$6.02M
Price to Earnings (P/E)-6.1
Beta0.69
Aug 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding53,209,361
10 Day Avg. Volume1,880
30 Day Avg. Volume15,715
Standard Deviation0.19
R-Squared0.00567
Alpha0.00732
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

16.25%0.00%0.00%83.75%
16.25% Insiders
0.00% Other Institutional Investors
83.75% Public Companies and
Individual Investors

VBS FAQ

What was Vectus Biosystems Limited’s price range in the past 12 months?
Vectus Biosystems Limited lowest share price was AU$0.10 and its highest was AU$0.65 in the past 12 months.
    What is Vectus Biosystems Limited’s market cap?
    Currently, no data Available
    When is Vectus Biosystems Limited’s upcoming earnings report date?
    Vectus Biosystems Limited’s upcoming earnings report date is Aug 28, 2024 which is in 153 days.
      How were Vectus Biosystems Limited’s earnings last quarter?
      Vectus Biosystems Limited released its earnings results on Feb 23, 2024. The company reported -AU$0.022 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.022.
        Is Vectus Biosystems Limited overvalued?
        According to Wall Street analysts Vectus Biosystems Limited’s price is currently same. Get more investment ideas with TipRanks Premium
          Does Vectus Biosystems Limited pay dividends?
          Vectus Biosystems Limited does not currently pay dividends.
          What is Vectus Biosystems Limited’s EPS estimate?
          Vectus Biosystems Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Vectus Biosystems Limited have?
          Vectus Biosystems Limited has 53,209,362 shares outstanding.
            What happened to Vectus Biosystems Limited’s price movement after its last earnings report?
            Vectus Biosystems Limited reported an EPS of -AU$0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Vectus Biosystems Limited?
              Currently, no hedge funds are holding shares in AU:VBS
              ---

              Vectus Biosystems Limited Stock Smart Score

              4
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -48.18%
              12-Months-Change

              Fundamentals

              Return on Equity
              -77.56%
              Trailing 12-Months
              Asset Growth
              -45.18%
              Trailing 12-Months

              Company Description

              Vectus Biosystems Limited

              Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Vita Life Sciences Limited
              Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
              Chimeric Therapeutics Ltd.
              Radiopharm Theranostics Limited
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis